Zymeworks (ZYME) Times Interest Earned (2021 - 2026)
Zymeworks (ZYME) reported Times Interest Earned of -$2.43 for Q1 2026, up 90.06% on a YoY basis from -$1.28 in Q1 2025, and up 94.11% sequentially from -$41.26 in Q4 2025.
Zymeworks (ZYME) Times Interest Earned (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Times Interest Earned data on file, last reported at -$2.43 in Q1 2026.
- For the quarter ending Q1 2026, Times Interest Earned rose 90.06% year-over-year to -$2.43; the trailing twelve-month figure through Mar 2026 stood at -$5.88 (up 81.83% YoY), and the FY2025 full-year result was -$0.34, up 38.71% from the prior year.
- Times Interest Earned climbed to -$2.43 in Q1 2026, from -$41.26 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $289.57 in Q4 2022 to a low of -$48.68 in Q2 2024.
- A 5-year average of $2.89 and a median of -$17.31 in 2023 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned jumped 4037.81% in 2022 and plunged 3216.27% in 2024, its largest moves.
- Tracing ZYME's Times Interest Earned over 5 years: stood at $289.57 in 2022, then tumbled by 105.98% to -$17.31 in 2023, then sank by 34.11% to -$23.22 in 2024, then sank by 77.74% to -$41.26 in 2025, then surged by 94.11% to -$2.43 in 2026.
- Business Quant data shows ZYME's Times Interest Earned at -$2.43 in Q1 2026, -$41.26 in Q4 2025, and -$20.53 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Zymeworks | 1.73 Bn | 1.36 Bn | - | -2.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.43 |
| Dec 31, 2025 | -41.26 |
| Sep 30, 2025 | -20.53 |
| Jun 30, 2025 | -0.03 |
| Mar 31, 2025 | -24.44 |
| Dec 31, 2024 | -23.22 |
| Sep 30, 2024 | -35.15 |
| Jun 30, 2024 | -48.68 |
| Mar 31, 2024 | -28.19 |
| Dec 31, 2023 | -17.31 |
| Sep 30, 2023 | -1.07 |
| Jun 30, 2023 | -1.70 |
| Mar 31, 2023 | -0.85 |
| Dec 31, 2022 | 289.57 |
| Sep 30, 2022 | -1.43 |
| Dec 31, 2021 | -7.35 |